Latest Health News

BlinkLab Limited has raised A$7.66 million through a well-supported placement to accelerate FDA regulatory trials for its autism and ADHD diagnostic platforms, leveraging its innovative smartphone-based technology.

Eureka Group Holdings has upsized its debt facilities to $185 million with improved terms, enhancing its financial flexibility to expand residential developments across Australia.

Anatara Lifesciences has obtained a $400,000 loan advance from a major shareholder group against its estimated R&D tax refund for the first half of FY2025, providing crucial funding to support ongoing clinical trials and product development without immediate capital raising.

Memphasys Limited has completed a pivotal Phase III trial confirming its Felix™ System as best-in-class for sperm separation, while advancing regulatory and commercial efforts in China and Brazil supported by fresh capital.

EMU NL’s latest quarterly report reveals promising copper exploration parallels with Canada’s largest open-pit mine, a renewed gold project strategy, and significant corporate restructuring amid shareholder disputes.

Macro Metals Limited has secured $2 million from a strategic placement to Paramount Earthmoving, advanced exploration across multiple Pilbara projects, and entered a second majority Indigenous-owned joint venture, positioning itself for growth in mining services.

Duxton Water Limited reported its strongest quarterly performance since inception, with NAV per share rising 17 cents to $1.71, driven by a $121.3 million sale of water entitlements to the Australian Government and strategic portfolio moves.

Po Valley Energy delivered steady gas output from its Podere Maiar-1 well in Q1 2025 while progressing multi-well drilling applications and a 3D geophysical survey in Italy. The company maintains robust cashflow and a solid financial position as it awaits key regulatory approvals.

Oldfields Holdings Limited reports solid progress in Q3 FY2025, driven by strategic transformation, debt reduction, and a robust sales pipeline supporting a positive outlook for the second half of the year.

HeraMED reports strong Q1 FY25 progress with 4,282 registered users on its HeraCARE platform, a new collaboration with Garmin Health, and advancing commercial deals in the US and Europe. Early clinical data suggests improved maternal outcomes and operational efficiencies.

Bridge SaaS Limited reports a 7% increase in NDIS participant numbers through its majority-owned Brightside, while advancing regional expansion and targeting cash flow positivity by refining operational efficiencies.

Nutritional Growth Solutions reported a 24.7% revenue decline in Q1 FY25 but bolstered its financial position with a $1 million AUD convertible note placement, while preparing for major retail launches at CVS and Walmart.